Wound Healing Supplement Market
Wound Healing Supplement Market Study by Chronic and Acute Wounds for Hospitals, Clinics, Research & Development, and Specialized Healthcare Centers From 2024 to 2034
Analysis of Wound Healing Supplement Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Wound Healing Supplement Market Outlook (2024 to 2034)
According to a new industry report released by Fact.MR, revenue from the global wound healing supplement market is approximated at US$ 22.58 billion in 2024 and has been evaluated to expand at a CAGR of 7.5% to achieve a value of US$ 46.34 billion by the end of 2034.
Chronic illnesses, such as diabetes, vascular disorders, and obesity cause wounds that heal slowly or not at all, which is increasing the necessity of the use of supplements that fasten the healing process. For these patients, nutritional supplementation is becoming essential, which is driving demand for specific wound rehabilitation solutions.
More patients and medical professionals are using supplements as part of their rehabilitation due to an increasing understanding of the importance of nutrition in wound healing because of continuous digital campaigns and the internet. Important nutrients that are known to aid in tissue repairs, such as zinc, vitamin C, and amino acids, are widely included in formulae for wound healing.
Because they speed up recovery and lower inflammation, wound healing supplements are beneficial for post-surgical patients and are becoming more widely used in clinics, hospitals, and home care settings.
North America is projected to account for 33.9% of the worldwide wound healing supplement market share in 2024 and has been forecasted to rise at an excellent CAGR of 9.1% over the next ten years. This region is providing lucrative opportunities to market players due to the increasing prevalence of chronic diseases, including diabetes, which are associated with slow-healing wounds.
Based on supplement type, the demand for nutrition wound healing supplements is evaluated to reach US$ 19.06 billion by 2034. To achieve health objectives, people are increasingly using dietary supplements and fortified foods that help to enhance mental health, immunological function, and the management of chronic diseases.
| Report Attribute | Detail |
|---|---|
| Wound Healing Supplement Market Size (2024E) | US$ 22.58 Billion |
| Forecasted Market Value (2034F) | US$ 46.34 Billion |
| Global Market Growth Rate (2024 to 2034) | 7.5% CAGR |
| North America Market Share (2024E) | 33.9% |
| Western Europe Market Value (2024E) | US$ 5.01 Billion |
| South Asia & Pacific Market Growth Rate (2024 to 2034) | 9.2% CAGR |
| Chronic Wound Segment Value (2034F) | US$ 29 Billion |
| Tablet Segment Value (2034F) | US$ 13.37 Billion |
| Key Companies Profiled | Abbot Nutrition; Nutrova; The Derma Co; DermaRite Industries; LLorens Pharmaceutical International Division Inc.; Global Health Products; Karmer Novis; Vitabiotics; Nestle Health Science; Lupin; Glaxosmithkline; Micro Labs; Macleods; Mankind Pharma; Bluecross; Intas; USV; Pfizer; Aristo Pharma; Cadila Pharma |
Market growth is aimed to increase due to factors, such as the rapidly growing geriatric population, rising incidence of diabetes, technological advancements in wound healing supplements, funding for wound care research, growing awareness of wound management, and increasing awareness for the use of the nutritive supplements.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What is Driving Demand for Wound Healing Market?
The frequency of chronic wounds has increased significantly over the years, basically due to the growing global geriatric population and the increasing patients of with obesity and diabetes.
Diabetes and obesity result in an increased overall incidence and complexity of wounds, such as infections, ulcerations (leg & foot ulcers), and surgical wounds, which require treatments and incur exorbitant medical expenses, this is positively influencing the demand for wound healing.
As per the Nanjing University Medical School Article, the number of people affected by diabetic foot ulcers in North America recorded was 13.0% and the Annual Growth Recorded was 2-5%. This is a major cause of the high demand for wound healing products.
United States and Canada Wound Healing Market Outlook
North America dominated the global wound healing market in 2020. Some of the reasons behind the growth of the market are the increasing geriatric population, growing demand for wound healing products in home care settings, and increased awareness among patients are major factors driving the growth of the wound care market currently.
As per the American Pediatric Medical Association (APMA) 2020, diabetes is the major cause of non-traumatic lower extremity amputations in the United States, and approximately 14-24% of patients with foot ulcers require an amputation. A study conducted by the Wound Healing Society (WHS) in, the United States, revealed that approximately 8.2 million people had wounds with or without infection in 2018 in the United States and the total cost of Medicare for acute and chronic wounds was around USD 21.1 - 96.8 billion.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Europe Demand & Outlook for Wound Healing Market
Europe's advanced wound healing market is mainly driven by technological advances, the rising importance of nutritional values, the rising geriatric population, and patients suffering from diabetes. According to the National Institute of Health, Many of the people in the United Kingdom are suffering from diabetes.
Furthermore, rising problems associated with ineffective traditional wound healing methods, initiatives taken by the government, and a pressing need for swift and safer treatment of chronic wounds are also driving the wound healing market in the region.
Who are the Key Manufacturers and Suppliers of Wound Healing Products?
Some of the Key Players in the wound healing supplement market are
- Abbot Nutrition
- Nutrova
- The Derma Co
- DermaRite Industries
- LLorens Pharmaceutical International Division Inc.
- Global Health Products
- Karmer Novis
- Vitabiotics
- Nestle Health Science
- Lupin
- Glaxosmithkline
- Micro Labs
- Macleods
- Mankind Pharma
- Bluecross
- Intas
- USV
- Pfizer
- Aristo Pharma
- Cadila Pharma
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Wound Healing Supplement Market Report Highlights:
- Detailed overview of the parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current, and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint
Segmentation of Wound Healing Supplement Market Research
-
By Wound Type :
- Chronic
- Diabetic Foot Ulcer
- Pressure Ulcer
- Arterial and Venous Ulcer
- Other Chronic Wounds
- Acute
- Surgical Wounds
- Burns
- Other Acute Wounds
- Chronic
-
By Supplement Type :
- Nutrition
- Antibiotic
- Herbal
-
By Dosage Form :
- Tablets
- Capsules
- Powder
- Liquid
- Ointment
- Creams
-
By End Users :
- Hospitals
- Clinics
- Research & Development
- Specialized Healthcare Centers
-
By Region :
- North America
- Western Europe
- Eastern Europe
- Latin America
- East Asia
- South Asia & Pacific
- Middle East & Africa
Table of Content
- 1. Executive Summary
- 2. Industry Introduction, including Taxonomy and Market Definition
- 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
- 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections
- 5. Pricing Analysis
- 6. Global Market Analysis and Forecast
- 7. Global Market Analysis and Forecast, By Wound Type
- 7.1. Chronic Wound
- 7.2. Acute Wound
- 8. Global Market Analysis and Forecast, By Supplement Type
- 8.1. Nutrition
- 8.2. Antibiotic
- 8.3. Herbal
- 9. Global Market Analysis and Forecast, By Dosage Form
- 9.1. Tablet
- 9.2. Capsule
- 9.3. Powder
- 9.4. Liquid
- 9.5. Ointment
- 9.6. Creams
- 10. Global Market Analysis and Forecast, By End Users
- 10.1. Hospitals
- 10.2. Clinics
- 10.3. Research & Development
- 10.4. Specialized healthcare centres
- 11. Global Market Analysis and Forecast, By Region
- 11.1. North America
- 11.2. Latin America
- 11.3. Western Europe
- 11.4. Eastern Europe
- 11.5. East Asia
- 11.6. South Asia & Pacific
- 11.7. MEA
- 12. North America Sales Analysis and Forecast, by Key Segments and Countries
- 13. Latin America Sales Analysis and Forecast, by Key Segments and Countries
- 14. Western Europe Sales Analysis and Forecast, by Key Segments and Countries
- 15. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries
- 16. East Asia Sales Analysis and Forecast, by Key Segments and Countries
- 17. South Asia & Pacific Sales Analysis and Forecast, by Key Segments and Countries
- 18. MEA Sales Analysis and Forecast, by Key Segments and Countries
- 19. Sales Forecast by Wound Type, Supplement Type, Dosage Form, and End Users for 30 Countries
- 20. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
- 21. Company Profile
- 21.1. Abbot Nutrition
- 21.2. Nutrova
- 21.3. The Derm co
- 21.4. DermaRite Industries
- 21.5. LLorens Pharmaceutical International Division Inc
- 21.6. Global Health Products
- 21.7. Karmer Novis
- 21.8. Vitabiotics
- 21.9. Nestle Health science
- 21.10. Lupin
- 21.11. Glaxosmithkline
- 21.12. Micro Labs
- 21.13. Macleods
- 21.14. Mankind Pharma
- 21.15. Bluecross
- 21.16. Intas
- 21.17. USV
- 21.18. Pfizer
- 21.19. Aristo Pharma
- 21.20. Cadila Pharma
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market US$ Bn Forecast by Region
Table 2: Global Market US$ Bn Forecast by Wound Type
Table 3: Global Market US$ Bn Forecast by Supplement Type
Table 4: Global Market US$ Bn Forecast by Dosage Form
Table 5: Global Market US$ Bn Forecast by End Users
Table 6: North America Market US$ Bn Forecast by Country
Table 7: North America Market US$ Bn Forecast by Wound Type
Table 8: North America Market US$ Bn Forecast by Supplement Type
Table 9: North America Market US$ Bn Forecast by Dosage Form
Table 10: North America Market US$ Bn Forecast by End Users
Table 11: Latin America Market US$ Bn Forecast by Country
Table 12: Latin America Market US$ Bn Forecast by Wound Type
Table 13: Latin America Market US$ Bn Forecast by Supplement Type
Table 14: Latin America Market US$ Bn Forecast by Dosage Form
Table 15: Latin America Market US$ Bn Forecast by End Users
Table 16: Western Europe Market US$ Bn Forecast by Country
Table 17: Western Europe Market US$ Bn Forecast by Wound Type
Table 18: Western Europe Market US$ Bn Forecast by Supplement Type
Table 19: Western Europe Market US$ Bn Forecast by Dosage Form
Table 20: Western Europe Market US$ Bn Forecast by End Users
Table 21: Eastern Europe Market US$ Bn Forecast by Country
Table 22: Eastern Europe Market US$ Bn Forecast by Wound Type
Table 23: Eastern Europe Market US$ Bn Forecast by Supplement Type
Table 24: Eastern Europe Market US$ Bn Forecast by Dosage Form
Table 25: Eastern Europe Market US$ Bn Forecast by End Users
Table 26: East Asia Market US$ Bn Forecast by Country
Table 27: East Asia Market US$ Bn Forecast by Wound Type
Table 28: East Asia Market US$ Bn Forecast by Supplement Type
Table 29: East Asia Market US$ Bn Forecast by Dosage Form
Table 30: East Asia Market US$ Bn Forecast by End Users
Table 31: South Asia & Pacific Market US$ Bn Forecast by Country
Table 32: South Asia & Pacific Market US$ Bn Forecast by Wound Type
Table 33: South Asia & Pacific Market US$ Bn Forecast by Supplement Type
Table 34: South Asia & Pacific Market US$ Bn Forecast by Dosage Form
Table 35: South Asia & Pacific Market US$ Bn Forecast by End Users
Table 36: MEA Market US$ Bn Forecast by Country
Table 37: MEA Market US$ Bn Forecast by Wound Type
Table 38: MEA Market US$ Bn Forecast by Supplement Type
Table 39: MEA Market US$ Bn Forecast by Dosage Form
Table 40: MEA Market US$ Bn Forecast by End Users
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Wound Type
Figure 2: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Supplement Type
Figure 3: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Dosage Form
Figure 4: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End Users
Figure 5: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Region
Figure 6: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Wound Type
Figure 7: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Supplement Type
Figure 8: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Dosage Form
Figure 9: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End Users
Figure 10: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Figure 11: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Wound Type
Figure 12: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Supplement Type
Figure 13: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Dosage Form
Figure 14: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End Users
Figure 15: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Figure 16: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Wound Type
Figure 17: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Supplement Type
Figure 18: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Dosage Form
Figure 19: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End Users
Figure 20: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Figure 21: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Wound Type
Figure 22: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Supplement Type
Figure 23: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Dosage Form
Figure 24: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End Users
Figure 25: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Figure 26: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Wound Type
Figure 27: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Supplement Type
Figure 28: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Dosage Form
Figure 29: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End Users
Figure 30: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Figure 31: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Wound Type
Figure 32: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Supplement Type
Figure 33: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Dosage Form
Figure 34: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End Users
Figure 35: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Figure 36: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Wound Type
Figure 37: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Supplement Type
Figure 38: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Dosage Form
Figure 39: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End Users
Figure 40: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How much growth potential does the wound healing supplement market hold?
The wound healing supplement market is projected to grow at a CAGR of 7.5% during the forecast period.
Why does the wound healing supplement market have high growth potential?
The market is expanding due to the swiftly climbing geriatric population coupled with the increasing rate of diabetes.
Where will manufacturers find the most opportunities in the wound healing supplement industry?
Manufacturers are finding remunerative opportunities in North America.
Wound Healing Supplement Market